Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07646860 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT07646860 · ClinicalTrials.gov record · last posted 2026-08-19

A Study of Sotatercept (MK-7962) in Japanese Children With Pulmonary Arterial Hypertension (PAH) (MK-7962-032)

StatusRecruiting
PhasePhase 2
Started2026-08-31
View on ClinicalTrials.gov ↗
from the ClinicalTrials.gov record
The goal of this study is to learn about the safety of sotatercept and how well Japanese children tolerate it, when taken along with standard (usual) pulmonary arterial hypertension (PAH) treatment. Researchers also want to learn what happens to it in a person's body over time and whether it lowers resistance in blood vessels in the lungs.

Protocol amendment history 1 change detected by DataLookout

2026-08-20
Recruitment opened
Trial Details
NCT Number NCT07646860
Lead Sponsor Merck Sharp & Dohme LLC
Conditions Pulmonary Arterial Hypertension
Enrollment 6 participants
Start Date 2026-08-31
Primary Completion 2029-05-24 (estimated)
Study Completion 2031-05-16 (estimated)
Updated on ClinicalTrials.gov 2026-08-19